Monday, November 16, 2026
  • Login
CEO North America
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
No Result
View All Result
CEO North America
No Result
View All Result

CEO NA Magazine > News > Pfizer submits data to FDA for authorization of Covid vaccine booster

Pfizer submits data to FDA for authorization of Covid vaccine booster

in News
Pfizer submits data to FDA for authorization of Covid vaccine booster
Share on LinkedinShare on WhatsApp

Pfizer and BioNTech said Monday they have submitted early-stage clinical trial data to the Food and Drug Administration as part of their U.S. application seeking authorization of a Covid vaccine booster for everyone 16 and older.

In a phase one trial, a booster dose of the vaccine generated “significantly higher neutralizing antibodies” against not only the original coronavirus strain, but also the beta and delta variants, the companies said in a press release. Participants in the trial received a third dose of the two-dose vaccine about eight to nine months after receiving their second shot, they said.

“The data we’ve seen to date suggest a third dose of our vaccine elicits antibody levels that significantly exceed those seen after the two-dose primary schedule,” Pfizer CEO Albert Bourla said in a statement. “We are pleased to submit these data to the FDA as we continue working together to address the evolving challenges of this pandemic.”

The companies said late-stage trial results evaluating the third dose are expected shortly and will also be submitted to the FDA and other regulatory authorities worldwide.

Tags: Pfizer vaccine

Related Posts

Nvidia due in Supreme Court today
News

Nvidia stock falls as execs push for Huang’s return

Warren Buffett Becomes HP Top Shareholder
News

Buffett donates $5.5 billion, urges kindness in Thanksgiving letter

Eli Lilly pledges $6 billion manufacturing plant in Alabama
News

Lilly to acquire Calytrix Bio in $1.5 billion deal

Trump pardons Founder and former CEO of Binance
News

$1.2 billion in stolen Binance crypto seized by U.S.

U.S. officials order Nvidia to stop sales of AI chips to China
News

Nvidia stock continues to fall following Huang’s resignation

Microsoft outage still affecting millions of users
News

Microsoft outage still affecting millions of users

Nebius secures $3 billion deal with Meta
News

Nebius falls 10% on weak outlook

Siemens CEO says company is ready for tariffs
News

Siemens CEO vows to maintain partnership with Nvidia

Hiring Jensen Huang would be an ‘honor,’ says Musk
News

Hiring Jensen Huang would be an ‘honor,’ says Musk

Barrick CEO says copper remains on a positive trajectory despite 50% tariffs
News

Barrick Mining files for IPO of North American business

No Result
View All Result

Recent Posts

  • How high-income earners can reduce taxes before year-end
  • Intel sued by shareholders following 29% stock plunge
  • Nvidia stock falls as execs push for Huang’s return
  • Buffett donates $5.5 billion, urges kindness in Thanksgiving letter
  • Lilly to acquire Calytrix Bio in $1.5 billion deal

Archives

Categories

  • Art & Culture
  • Business
  • CEO Interviews
  • CEO Life
  • Editor´s Choice
  • Entrepreneur
  • Environment
  • Food
  • Health
  • Highlights
  • Industry
  • Innovation
  • Issues
  • Management & Leadership
  • News
  • Opinion
  • PrimeZone
  • Printed Version
  • Technology
  • Travel
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 2125 9933 0330

UK
Collingwood Buildings,
38 Collingwood Street,
Newcastle Upon Tyne
NE1 1JF

  • News
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life

  • CONTACT
  • GENERAL ENQUIRIES
  • ADVERTISING
  • MEDIA KIT
  • DIRECTORY
  • TERMS AND CONDITIONS

Advertising –
advertising@ceo-na.com

110 Wall St.,
3rd Floor
New York, NY.
10005
USA
+1 2125 9933 0330

UK
Collingwood Buildings,
38 Collingwood Street,
Newcastle Upon Tyne
NE1 1JF

CEO North America © 2024 - Sitemap

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • Opinion
  • Technology
  • Environment
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.